Pricing Log in Create free account

Corvus Pharmaceuticals, Inc. (CRVS) vs Syndax Pharmaceuticals, Inc. (SNDX)

Corvus Pharmaceuticals, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($843.6M and $818.5M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −72.4%) and the lower return on invested capital (−352.5% vs −83.4%). Across the 13 metrics below, Corvus Pharmaceuticals, Inc. leads on 9 and Syndax Pharmaceuticals, Inc. on 4.

Valuation

Metric CRVS SNDX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.96 9.40
P/B 4.33 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 3.56 9.02
Earnings yield (5.77%) (24.74%) (32.88%)
Free cash flow yield (4.63%) (20.73%) (23.13%)

Profitability

Metric CRVS SNDX Biotechnology median
Gross margin 0.00% 92.21% 68.51%
Operating margin 0.00% (61.72%) 0.00%
Net margin 0.00% (72.38%) 0.00%
Free cash flow margin 0.00% (61.36%) 0.00%
Return on equity (35.43%) (426.43%) (51.96%)
Return on assets (32.93%) (33.67%) (46.06%)
Return on invested capital (352.49%) (83.42%) 0.00%

Growth

Metric CRVS SNDX Biotechnology median
Revenue growth (TTM) — 159.46% 6.76%
EPS growth (last fiscal year) 48.04% 11.56% 29.88%
Revenue growth, 5-year CAGR — 157.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVS SNDX Biotechnology median
Debt to equity 0.00 (34.24) 0.00
Current ratio 16.16 4.69 4.97
Net debt to EBITDA 1.28 0.25 1.01

Dividend

Metric CRVS SNDX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVS SNDX Biotechnology median
Market cap 818.50m 843.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack